The introduction of all-trans retinoic acid in 1985 combined with anthracycline-based chemotherapy has revolutionized the prognosis of acute promyelocytic leukemia (APL) with current complete ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback